Chemoinformaics analysis of (Z)-Nuciferol acetate
| Molecular Weight | 260.377 | nRot | 6 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 8 |
| Exact Molecular Weight | 260.178 | nRing | 1 |
| Solubility: LogS | -4.339 | nHRing | 0 |
| Solubility: LogP | 4.204 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 45.997 |
| nHD | 0 | BPOL | 26.681 |
| QED | 0.56 |
| Synth | 2.685 |
| Natural Product Likeliness | 1.067 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.834 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.565 |
| MDCK | 0.0000199 |
| BBB | 0.922 |
| PPB | 0.954311 |
| VDSS | 2.81 |
| FU | 0.067586 |
| CYP1A2-inh | 0.927 |
| CYP1A2-sub | 0.732 |
| CYP2c19-inh | 0.858 |
| CYP2c19-sub | 0.762 |
| CYP2c9-inh | 0.744 |
| CYP2c9-sub | 0.671 |
| CYP2d6-inh | 0.553 |
| CYP2d6-sub | 0.853 |
| CYP3a4-inh | 0.661 |
| CYP3a4-sub | 0.659 |
| CL | 4.774 |
| T12 | 0.759 |
| hERG | 0.075 |
| Ames | 0.056 |
| ROA | 0.033 |
| SkinSen | 0.823 |
| Carcinogencity | 0.525 |
| EI | 0.914 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.797183 |